Serono Serostim Counterfeits May Have Originated In Asia, FDA Says

Counterfeit versions of Serono's Serostim recently found in the U.S. may have originated in Asia, FDA Senior Associate Commissioner for Policy, Planning & Legislation William Hubbard told the Senate Commerce/Consumer Affairs Subcommittee Sept. 5.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet